Lukas Koch

8PUBLICATIONS
8CO-AUTHORS
Characterisation of biological macromoleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineMedical infection agents (incl. prions)Te mātai tahumaero o te Māori (Māori epidemiology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 08, 2025
Non-genetic factors associated with ACE-inhibitor and angiotensin receptor blocker-induced angioedema.

Diana Dubrall, Nora L Branding, Carina M Mathey

|Mar 15, 2025
A Safe and Efficient 7-Week Immunotherapy Protocol With Aluminum Hydroxide Adsorbed Bee Venom.

Lisa Arzt-Gradwohl, Urban Čerpes, Eva Schadelbauer

|Nov 20, 2024
Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis.

M Brandlmaier, M Hoellwerth, T Silly

|Mar 28, 2023
Molecular allergy diagnosis is sensitive and avoids misdiagnosis in patients sensitized to seasonal allergens.

Lukas Koch, Karin Laipold, Lisa Arzt-Gradwohl

|Jan 16, 2023
Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.

Lukas Buchacher, Georg Richtig, Marie Dernoscheg

|Apr 26, 2022
Long-term adherence to melanoma follow-up examinations - a telephone survey.

L Buchacher, G Richtig, C Schöffl

Pageof 2